| Dipeptidyl peptidase-4 inhibitor–associated pancreatic carcinoma: a review of the FAERS database AK Nagel, N Ahmed-Sarwar, PM Werner, GC Cipriano, RP Van Manen, ... Annals of Pharmacotherapy 50 (1), 27-31, 2016 | 34 | 2016 |
| Signal detection methodologies to support effective safety management RP van Manen, D Fram, W DuMouchel Expert Opinion on Drug Safety 6 (4), 451-464, 2007 | 32 | 2007 |
| Tigecycline‐related pancreatitis: a review of spontaneous adverse event reports E Okon, C Engell, R van Manen, J Brown Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (1 …, 2013 | 31 | 2013 |
| Lysosomal activity in the aging rat liver: II. Morphometry of acid phosphatase positive dense bodies W De Priester, R Van Manen, DL Knook Mechanisms of ageing and development 26 (2-3), 205-216, 1984 | 29 | 1984 |
| Lysosomal activity in aging rat liver: I. Variation in enzyme activity within the liver lobule R Van Manen, W De Priester, DL Knook Mechanisms of ageing and development 22 (2), 159-165, 1983 | 20 | 1983 |
| A review of the food and drug administration adverse event reporting system for tramadol-related hypoglycemia KM Juba, RP van Manen, SE Fellows Annals of Pharmacotherapy 54 (3), 247-253, 2020 | 11 | 2020 |
| Potential for linezolid‐related blindness: a review of spontaneous adverse event reports J Brown, SL Aitken, RP van Manen Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (6 …, 2011 | 10 | 2011 |
| Signal detection for bleeding associated with the use of direct oral anticoagulants KT Nathan, KM Conn, RP van Manen, JE Brown The Bulletin of the American Society of Hospital Pharmacists 75 (13), 973-977, 2018 | 8 | 2018 |
| How Safe Are Recently FDA‐Approved Antimicrobials? A Review of the FDA Adverse Event Reporting System Database TM Khadem, RP van Manen, J Brown Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (12 …, 2014 | 7 | 2014 |
| Potential voriconazole associated posterior reversible leukoencephalopathy in children with malignancies: report of two cases A Amanati, M Lotfi, RV Manen, MA Faghihi, M Yavarian, O Zekavat, ... Journal of oncology pharmacy practice 27 (2), 498-504, 2021 | 2 | 2021 |
| A systematic analysis of drug name confusion using disproportionality analysis RP van Manen Association for Clinical Data Management Annual Conference, UK, 2014 | 1 | 2014 |
| A Central Database with Distributed Off-Line Data Entry and Correction: The Best of Both Worlds? RP van Manen, E Houthoff Drug Information Journal 27 (4), 957-962, 1993 | 1 | 1993 |
| Validating a Clinical Data System: Technical, Organizational, and Managerial Aspects RP van Manen, KJ de Neef Drug Information Journal 27 (2), 245-252, 1993 | 1 | 1993 |
| Identifying Patients at Risk in Clinical Trials using Data Mining and Data Visualization RP van Manen | | 2014 |
| Challenges in Safety Signal Detection and Management RP van Manen | | 2014 |
| Sitagliptin Associated Pancreatic Carcinoma: a Review of the FDA AERS Database A Nagel, G Cipriano, N Ahmed-Sarwar, R Van Manen, J Brown | | 2014 |
| Azithromycin associated risk of cardiovascular death from arrhythmia: a review of the FDA adverse event reporting system database. T Khadem, R Van Manen, J Brown PHARMACOTHERAPY 33 (10), E230-E231, 2013 | | 2013 |
| A Systematic Analysis of Drug Name Confusion in the FDA AERS Database Using Disproportionality Analysis RP van Manen PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 21, 348-348, 2012 | | 2012 |
| Implementing Signal Detection Best Practices Through Online Signal Management RP van Manen DIA Future Perspectives in Pharmacovigilance, Bangalore, India, 2012 | | 2012 |
| Can disproportionality analysis play a role in monitoring drug-eluting stent safety? H Duggirala, X Yang, R Van Manen CIRCULATION 118 (12), E439-E439, 2008 | | 2008 |
Katherine JubaWegmans School of PharmacyVerified email at sjfc.edu
